Keiji Nogami

Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

Midori Shima, Hideji Hanabusa, Masashi Taki et al. · New England Journal of Medicine · 2016 · 449 citations · Full text

Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens

Takehisa Kitazawa, Keiko Esaki, Tatsuhiko Tachibana et al. · Thrombosis and Haemostasis · 2017 · 193 citations · Full text

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni et al. · New England Journal of Medicine · 2023 · 160 citations · Full text

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Haemophilia · 2019 · 148 citations · Full text

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors

Midori Shima, Hideji Hanabusa, Masashi Taki et al. · Blood Advances · 2017 · 122 citations · Full text

Phase 1/2, Thrombosis, Translational Medicine +14